PROCEPT Q2 2026: revenue up 19% to $94.5M, record HYDROS placements, 816 US systems installed

PROCEPT BioRobotics/HYDROS Robotic System (Aquablation)

PROCEPT reported Q2 2026 revenue of $94.5M, up 19%, with more than 13,100 US procedures, up about 21%. It delivered 65 HYDROS systems in the US, 14 of them replacing older robots, ending June with 816 US systems. It kept full-year guidance of $390-410M revenue but lost $26.9M in the quarter.

• US revenue $83.4M, international $11.1M.
• New HYDROS selling price about $495,000; handpiece about $3,550.
• Gross margin 66%; net loss $26.9M.
• US installed base 816 systems at 30 June 2026.
• 2026 guidance: 54,000-56,000 US procedures.